tiprankstipranks
Trending News
More News >
Resmed Inc (CH:RME)
:RME
Advertisement

Resmed (RME) Price & Analysis

Compare
0 Followers

RME Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Bulls Say, Bears Say

Bulls Say
Acquisitions And GrowthThe VirtuOX acquisition is recognized in America’s mask and other sales that were up 12% reported.
Financial PerformanceRMD's F1Q26 revenue and EPS beat consensus.
Market PositionThere is a strong preference for Resmed Inc hardware over competitors, which suggests a robust market position.
Bears Say
Growth ConcernsOrganic revenue growth slowed to 7% in F1Q26 from 8% in F4Q25, marking the third consecutive quarter of slowing organic growth.
Market CompetitionConcerns are mounting that Eli Lilly's recent campaign may start to divert new patient starts from the top of the Sleep funnel.
Regulatory RisksThe section 232 investigation in the US into medtech products could impact the company via future tariffs.

Resmed News

RME FAQ

What was Resmed Inc’s price range in the past 12 months?
Currently, no data Available
What is Resmed Inc’s market cap?
Currently, no data Available
When is Resmed Inc’s upcoming earnings report date?
Resmed Inc’s upcoming earnings report date is Jan 22, 2026 which is in 74 days.
    How were Resmed Inc’s earnings last quarter?
    Resmed Inc released its earnings results on Oct 30, 2025. The company reported $2.052 earnings per share for the quarter, beating the consensus estimate of $2.026 by $0.027.
      Is Resmed Inc overvalued?
      According to Wall Street analysts Resmed Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Resmed Inc pay dividends?
        Resmed Inc does not currently pay dividends.
        What is Resmed Inc’s EPS estimate?
        Resmed Inc’s EPS estimate is 2.19.
          How many shares outstanding does Resmed Inc have?
          Currently, no data Available
          What happened to Resmed Inc’s price movement after its last earnings report?
          Resmed Inc reported an EPS of $2.052 in its last earnings report, beating expectations of $2.026. Following the earnings report the stock price went same N/A.
            Which hedge fund is a major shareholder of Resmed Inc?
            Currently, no hedge funds are holding shares in CH:RME

            Company Description

            Resmed Inc

            ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

            Resmed (RME) Earnings & Revenues

            RME Company Deck

            RME Earnings Call

            Q1 2025
            0:00 / 0:00
            Earnings Call Sentiment|Positive
            The earnings call reflected a strong quarter for ResMed with significant revenue growth, successful product launches, and improved gross margins. However, challenges remain in the SaaS business growth and increased tax rates due to global minimum tax legislation.View all CH:RME earnings summaries

            RME Revenue Breakdown

            51.79%51.79%35.75%12.46%
            51.79% Devices
            35.75% Masks and other
            12.46% Software as a Service
            tipranks
            Similar Stocks
            Company
            Price & Change
            Follow
            Baxter International
            Becton Dickinson
            Hologic
            Masimo
            West Pharmaceutical Services

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis